Trade IMCR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immunocore Holdings plc American Depositary Shares (IMCR) is trading at US$30.44, up 7.17% today as of Nov 6, 15:08 EST. The company has a market capitalisation of US$1.9B. Over the past 52 weeks, IMCR has traded between US$27.50 and US$40.71. On Syfe you can trade IMCR with $0 commission and add it to your watchlist.
| Previous close | US$28.40 |
|---|---|
| Market cap | US$1.9B |
| 52-week range | US$27.50 – US$40.71 |
| Volume | 372.28K |
| Exchange | US |
Immunocore Holdings plc American Depositary Shares
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Year: 2021
Immunocore Completes Enrollment in Study of Potential Advanced Melanoma Treatment
Sep 14, 11:46 AM · MT Newswires
Stay on top of IMCR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
